Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Yamane Medical Corporation Raises Consolidated Mid-year Outlook for FY 2014


Monday, 30 Sep 2013 02:05am EDT 

Yamane Medical Corporation announced that it has raised consolidated mid-year outlook for revenue from JPY 2,600 million to JPY 2,659 million, operating profit from JPY 62 million to JPY 171 million, ordinary profit from JPY 50 million to JPY 161 million, net profit from JPY 28 million to JPY 93 million, earning per share from JPY 255.71 to JPY 857.8 for the fiscal year ending February 2014. The positive outlook is mainly due to reduction of costs and increase of productivity. 

Company Quote

224.0
-1.0 -0.44%
12:57am EST